Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Henk Verheul"'
Autor:
Henk Verheul, Tanja de Gruijl, Elisa Toffoli, Abdolkarim Sheikhi, Roeland Lameris, Lisa King, Jurriaan Tuynman, Jan Spanholtz, Hans Van der Vliet
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/71c0306515094122a8cf926b1c58d71f
Autor:
Robbert S. Puijk, Alette H. Ruarus, Laurien G. P. H. Vroomen, Aukje A. J. M. van Tilborg, Hester J. Scheffer, Karin Nielsen, Marcus C. de Jong, Jan J. J. de Vries, Babs M. Zonderhuis, Hasan H. Eker, Geert Kazemier, Henk Verheul, Bram B. van der Meijs, Laura van Dam, Natasha Sorgedrager, Veerle M. H. Coupé, Petrousjka M. P. van den Tol, Martijn R. Meijerink, COLLISION Trial Group
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background Radiofrequency ablation (RFA) and microwave ablation (MWA) are widely accepted techniques to eliminate small unresectable colorectal liver metastases (CRLM). Although previous studies labelled thermal ablation inferior to surgical
Externí odkaz:
https://doaj.org/article/623580f03b0943f3baff8592f6874b61
Autor:
Michael Cannarile, Valeria Runza, Stefan Weigand, Valerie Meresse, Andrew L. Coveler, Devalingam Mahalingam, Carla van Herpen, Jean-Pierre Delord, Christophe Le Tourneau, Henk Verheul, Sabine Lohmann, Florian Heil, Konrad Honold, Adam Nopora, Edgar Voss, Fabian Birzele
Purpose: CD44, a cell surface glycoprotein, plays important roles in the development, progression, and metastasis of various tumor types. The aim of this study was to investigate how the expression of CD44 isoforms influences the interaction with hya
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0471a2b2e86dfb93e268dd809b75cb3d
https://doi.org/10.1158/1078-0432.c.6524757.v1
https://doi.org/10.1158/1078-0432.c.6524757.v1
Autor:
Michael Cannarile, Valeria Runza, Stefan Weigand, Valerie Meresse, Andrew L. Coveler, Devalingam Mahalingam, Carla van Herpen, Jean-Pierre Delord, Christophe Le Tourneau, Henk Verheul, Sabine Lohmann, Florian Heil, Konrad Honold, Adam Nopora, Edgar Voss, Fabian Birzele
Supplementary Methods, Figures (1-6) and Tables (1, 2 and 4). Supplementary Figure 1: Shows how RG7356 blocks binding of CD44-Fc to HA in a concentration dependent manner for two fixed CD44-Fc concentrations. Supplementary Figure 2: Shows hyaluronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30cdc6774cab1b66f39990c9e3e50834
https://doi.org/10.1158/1078-0432.22461303.v1
https://doi.org/10.1158/1078-0432.22461303.v1
Autor:
Michael Cannarile, Valeria Runza, Stefan Weigand, Valerie Meresse, Andrew L. Coveler, Devalingam Mahalingam, Carla van Herpen, Jean-Pierre Delord, Christophe Le Tourneau, Henk Verheul, Sabine Lohmann, Florian Heil, Konrad Honold, Adam Nopora, Edgar Voss, Fabian Birzele
Supplementary Tables 3, 5, 6 and 7. Supplementary Table 3: Contains the results of the differential gene expression analysis between CD44s HEK and native HEK cells (log ratios on the gene level and FDR corrected p-values) Supplementary Table 5: Conta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b593e404f13a9e85d2d7dcab2575f9e
https://doi.org/10.1158/1078-0432.22461300
https://doi.org/10.1158/1078-0432.22461300
Autor:
Sophie Gerritse, Mariette Labots, Rob ter Heine, Henk Dekker, Dennis Poel, Daniele Tauriello, Iris Nagtegaal, Erik Van Den Hombergh, Nielka Van Erp, Henk Verheul
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6061
Cancers, 14(24):6061. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 14
Gerritse, S L, Labots, M, Heine, R T, Dekker, H, Poel, D, Tauriello, D V F, Nagtegaal, I D, van den Hombergh, E, van Erp, N & Verheul, H M W 2022, ' High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid Tumors ', Cancers, vol. 14, no. 24, 6061 . https://doi.org/10.3390/cancers14246061
Cancers, 14, 24
Cancers, 14(24):6061. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 14
Gerritse, S L, Labots, M, Heine, R T, Dekker, H, Poel, D, Tauriello, D V F, Nagtegaal, I D, van den Hombergh, E, van Erp, N & Verheul, H M W 2022, ' High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid Tumors ', Cancers, vol. 14, no. 24, 6061 . https://doi.org/10.3390/cancers14246061
Cancers, 14, 24
Patients with advanced cancer refractory to standard treatment were treated with sunitinib at a dose of 300 mg once every week (Q1W) or 700 mg once every two weeks (Q2W). Tumor, skin and plasma concentrations were measured and immunohistochemical sta
Autor:
Nynke Greijdanus, Melissa Arron, Johannes de Wilt, Pieter Tanis, Harry van Goor, Henk Verheul, Richard ten Broek, Pauline Vissers, Rob Verhoeven
Publikováno v:
European Journal of Surgical Oncology. 48:e47
Autor:
Ahmet Celik, Maria Christiane Valeria Braga Braile-Sternieri, Denis Andreev, Yury Grinshtein, Andrzej Lubiński, Hans Prozesky, Olga Mirolyubova, Yaroslav Malynovsky, Michel GALINIER, Andrzej Madej, Felix Perez-Villa, Dariusz Kosior, Mandeep Mehra, Elena Shutemova, John Cleland, PASCUAL BORDES SISCAR, Henk Verheul, ROMAN FREIXA-PAMIAS
Publikováno v:
New England Journal of Medicine, 379(14), 1332-1342. MASSACHUSETTS MEDICAL SOC
Heart failure is associated with activation of thrombin-related pathways, which predicts a poor prognosis. We hypothesized that treatment with rivaroxaban, a factor Xa inhibitor, could reduce thrombin generation and improve outcomes for patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa09983d0a8f132bd68948e856db311e
http://hdl.handle.net/11379/518287
http://hdl.handle.net/11379/518287
Autor:
Meike De Wit, Jaco Knol, Inge de Reus, Tim Tim Schelfhorst, Logan Bishop-Currey, Nicole van Grieken, Sander Piersma, Thang V. Pham, Remond J. Fijneman, Gerrit A. Meijer, Henk Verheul, Connie R. Jimenez
Publikováno v:
Cancer Research. 77:2208-2208
Objective: Extracellular vesicles (EVs) are cell-secreted membrane vesicles enclosed by a lipid bilayer derived from endosomes or from the plasma membrane. Since they are released into body fluids, and their cargo includes tissue-specific and disease
Autor:
Rob Van der Luijt, Manuel Salto-Tellez, Elizabeth Bancroft, Katja Gaarenstroom, Edenir Palmero, Olivier Delattre, Yannick Bidet, Henk Verheul
Background: Nearly 15% of DNA tests for BRCA1/2 results in the identification of an unclassified variant (UV). In DNA diagnostic laboratories in The Netherlands, a 4-group classification system (class I to IV) is in use (Bell et al.). Aim of this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e505e0a639821659ced6ec523e042c36
https://europepmc.org/articles/PMC3320236/
https://europepmc.org/articles/PMC3320236/